Excessive Phlebotomy in Cardiac Surgical Care Leads to Anemia
By LabMedica International staff writers Posted on 01 Apr 2015 |

Image: Phlebotomy or venipuncture performed to obtain blood for laboratory tests (Photo courtesy of Sweet Water Health and Education).
Laboratory testing among patients undergoing cardiac surgery can lead to excessive bloodletting, which can increase the risk of developing hospital-acquired anemia and the need for blood transfusion.
Health care providers are seldom aware of the frequency and volume of phlebotomy for laboratory testing, bloodletting that often leads to nosocomial anemia. The frequency of laboratory testing in patients undergoing cardiac surgery, and the cumulative phlebotomy volume from time of initial surgical consultation to hospital discharge has been investigated.
Medical teams at the Cleveland Clinic (Cleveland, OH, USA) examined every laboratory test from 1,894 patients who underwent cardiac surgery from January to June 2012. The number and type of blood tests performed were recorded from the time patients met their surgeons until hospital discharge. The scientists then tallied up the total amount of blood taken from each patient. Phlebotomy volume was estimated separately for the intensive care unit (ICU), hospital floors, and cumulatively.
A total of 221,498 laboratory tests were performed, averaging 115 tests per patient. The most frequently performed tests were 88,068 blood gas analyses, 39,535 coagulation tests, 30,421 complete blood counts, and 29,374 metabolic panels. Phlebotomy volume differed between ICU and hospital floors, with median volumes of 332 mL and 118 mL, respectively. Cumulative median volume for the entire hospital stay was 454 mL. More complex procedures were associated with higher overall phlebotomy volume than isolated procedures. Foe combined coronary artery bypass grafting (CABG) and valve procedure, the median volume was 653 mL versus 448 mL for isolated CABG and 338 mL for isolated valve procedures.
Colleen G. Koch, MD, MS, MBA, the lead author of the study said, “We were astonished by the amount of blood taken from our patients for laboratory testing. Total phlebotomy volumes approached one to two units of red blood cells, which is roughly equivalent to one to two cans of carbonated beverage. Patients should feel empowered to ask their doctors whether a specific test is necessary, such as: What is the indication for the test? Will it change my care? And if so, do you need to do it every day? They should inquire whether smaller volume test tubes could be used for the tests that are deemed necessary. Every attempt should be made to conserve the patient's own blood, every drop of blood counts.” The study was published in the March 2015 issue of the journal the Annals of Thoracic Surgery.
Related Links:
Cleveland Clinic
Health care providers are seldom aware of the frequency and volume of phlebotomy for laboratory testing, bloodletting that often leads to nosocomial anemia. The frequency of laboratory testing in patients undergoing cardiac surgery, and the cumulative phlebotomy volume from time of initial surgical consultation to hospital discharge has been investigated.
Medical teams at the Cleveland Clinic (Cleveland, OH, USA) examined every laboratory test from 1,894 patients who underwent cardiac surgery from January to June 2012. The number and type of blood tests performed were recorded from the time patients met their surgeons until hospital discharge. The scientists then tallied up the total amount of blood taken from each patient. Phlebotomy volume was estimated separately for the intensive care unit (ICU), hospital floors, and cumulatively.
A total of 221,498 laboratory tests were performed, averaging 115 tests per patient. The most frequently performed tests were 88,068 blood gas analyses, 39,535 coagulation tests, 30,421 complete blood counts, and 29,374 metabolic panels. Phlebotomy volume differed between ICU and hospital floors, with median volumes of 332 mL and 118 mL, respectively. Cumulative median volume for the entire hospital stay was 454 mL. More complex procedures were associated with higher overall phlebotomy volume than isolated procedures. Foe combined coronary artery bypass grafting (CABG) and valve procedure, the median volume was 653 mL versus 448 mL for isolated CABG and 338 mL for isolated valve procedures.
Colleen G. Koch, MD, MS, MBA, the lead author of the study said, “We were astonished by the amount of blood taken from our patients for laboratory testing. Total phlebotomy volumes approached one to two units of red blood cells, which is roughly equivalent to one to two cans of carbonated beverage. Patients should feel empowered to ask their doctors whether a specific test is necessary, such as: What is the indication for the test? Will it change my care? And if so, do you need to do it every day? They should inquire whether smaller volume test tubes could be used for the tests that are deemed necessary. Every attempt should be made to conserve the patient's own blood, every drop of blood counts.” The study was published in the March 2015 issue of the journal the Annals of Thoracic Surgery.
Related Links:
Cleveland Clinic
Latest Clinical Chem. News
- New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
- New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
- Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
- Simple Urine Test Could Detect Multiple Cancers at Early Stage
- Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules
- First-Of-Its-Kind Quantitative Method Assesses Opioid Exposure in Newborns
- Paper-Based Devices Outperform Existing Methods in Diagnosing Asymptomatic Malaria
- Simple Skin Test Could Revolutionize Diagnosis of Pediatric Eosinophilic Esophagitis
- Portable Diagnostic Tool Uses Bioluminescence to Detect Viruses at POC
- AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress
- AI-Powered Blood Test Accurately Detects Ovarian Cancer
- Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
- Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
- First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
- Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
- ‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age
As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more
RNA Screening Test Could Detect Colon Polyps Before They Become Cancerous
Colorectal cancer has become a growing health crisis, especially as it increasingly affects younger adults in their 20s, 30s, and 40s, while screening rates remain low. Colorectal cancer is now the leading... Read more
New RT-LAMP Assay Offers Affordable and Reliable Pathogen Detection for Resource-Limited Settings
The high cost and logistical complexities associated with rapid, point-of-care tests have long hampered widespread access to molecular diagnostics, especially in low- and middle-income countries.... Read moreImmunology
view channel
Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more
Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels
Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more
New AI-Based Method Effectively Identifies Disease Phenotypes Using Light-Based Imaging
Precision medicine, where treatment strategies are tailored to a patient's unique disease characteristics, holds great promise for cancer therapy. However, identifying disease phenotypes, which are critical... Read more
AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care
Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read moreTechnology
view channel
Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
Cancer diagnosis is often delayed due to the difficulty in detecting early-stage cancer markers. In particular, the concentration of methylated DNA in the bloodstream during the early stages of cancer... Read moreIndustry
view channel
BD Biosciences & Diagnostic Solutions to Merge with Waters
BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and Waters Corporation (Milford, MA, USA) have entered into a definitive agreement to combine BD's Biosciences & Diagnostic Solutions... Read more